A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers
Clinical trial NCT05723692 · COMPLETED
Trial details
- NCT number
- NCT05723692
- Sponsor
- AltruBio Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-17
- Primary completion
- 2023-10-27
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.